Barayan, Maria Angelie M.
HRN: 06-18-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2023
CEFUROXIME 500MG (TAB)
03/22/2023
03/29/2023
ORAL
500mg
BID
S/P NSVD With RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes